NO996287D0 - Chalkoner med antiproliferativ aktivitet - Google Patents

Chalkoner med antiproliferativ aktivitet

Info

Publication number
NO996287D0
NO996287D0 NO996287A NO996287A NO996287D0 NO 996287 D0 NO996287 D0 NO 996287D0 NO 996287 A NO996287 A NO 996287A NO 996287 A NO996287 A NO 996287A NO 996287 D0 NO996287 D0 NO 996287D0
Authority
NO
Norway
Prior art keywords
pct
compounds
chalcones
date dec
relates
Prior art date
Application number
NO996287A
Other languages
English (en)
Other versions
NO996287L (no
NO314802B1 (no
Inventor
Ezio Bombardelli
Piero Valenti
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of NO996287D0 publication Critical patent/NO996287D0/no
Publication of NO996287L publication Critical patent/NO996287L/no
Publication of NO314802B1 publication Critical patent/NO314802B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
NO19996287A 1997-06-19 1999-12-17 Chalkoner med antiproliferativ aktivitet, farmasöytisk preparat samt anvendelse NO314802B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9712966.2A GB9712966D0 (en) 1997-06-19 1997-06-19 Novel chalcones
PCT/EP1998/003558 WO1998058913A1 (en) 1997-06-19 1998-06-12 Chalcones having antiproliferative activity

Publications (3)

Publication Number Publication Date
NO996287D0 true NO996287D0 (no) 1999-12-17
NO996287L NO996287L (no) 2000-02-21
NO314802B1 NO314802B1 (no) 2003-05-26

Family

ID=10814591

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19996287A NO314802B1 (no) 1997-06-19 1999-12-17 Chalkoner med antiproliferativ aktivitet, farmasöytisk preparat samt anvendelse

Country Status (22)

Country Link
US (1) US6147082A (no)
EP (1) EP0989973B1 (no)
JP (1) JP4064471B2 (no)
KR (1) KR20010013603A (no)
CN (1) CN1198802C (no)
AT (1) ATE303362T1 (no)
AU (1) AU742784C (no)
CA (1) CA2294278C (no)
CZ (1) CZ294976B6 (no)
DE (1) DE69831409T2 (no)
DK (1) DK0989973T3 (no)
ES (1) ES2244075T3 (no)
GB (1) GB9712966D0 (no)
HK (1) HK1023770A1 (no)
HU (1) HU227628B1 (no)
NO (1) NO314802B1 (no)
PL (1) PL190495B1 (no)
PT (1) PT989973E (no)
RU (1) RU2203883C2 (no)
SI (1) SI0989973T1 (no)
SK (1) SK283077B6 (no)
WO (1) WO1998058913A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7268160B2 (en) 2000-01-27 2007-09-11 Takara Bio, Inc. Remedies
KR100377514B1 (ko) * 2000-05-23 2003-03-26 신국현 찰콘 유도체, 그의 제조방법 및 그를 포함하는 약학적조성물
DE10060677A1 (de) 2000-12-05 2002-06-20 Aventis Pharma Gmbh Klainetine und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
AU2003243594A1 (en) * 2002-06-13 2003-12-31 Johns Hopkins University Novel boronic chalcone derivatives and uses thereof
WO2004030683A1 (ja) * 2002-10-01 2004-04-15 Takara Bio Inc. 治療剤
DK2447252T3 (da) * 2004-05-23 2020-03-16 Hmi Medical Innovations Llc Theramuteinmodulatorer
CN100336797C (zh) * 2005-08-19 2007-09-12 浙江大学 四取代查耳酮衍生物及制备方法和用途
CN102060792B (zh) * 2010-12-24 2016-08-03 西南大学 2′-胺基查尔酮唑类化合物及其吡唑啉和环丙基唑类衍生物、制备方法与用途
ES2540457B2 (es) * 2013-06-19 2015-12-28 Universidad De Sevilla Procedimiento de obtención de extractos de hojas de Corema album y su aplicación terapéutica
CN103360338B (zh) * 2013-07-30 2015-04-01 中国科学院新疆理化技术研究所 一种查尔酮苯并噻唑酰胺类衍生物的制备方法和用途
CN103910691A (zh) * 2014-04-18 2014-07-09 山东药品食品职业学院 卤代苯基查尔酮衍生物及其制备方法和应用
CN103896932A (zh) * 2014-04-18 2014-07-02 山东药品食品职业学院 异恶唑基芳基查尔酮衍生物及其制备方法和应用
CZ307046B6 (cs) * 2015-09-02 2017-12-13 Univerzita PalackĂ©ho v Olomouci Komplexy mědi s deriváty (E)-1-(2´-hydroxyfenyl)-3-fenylprop-2-en-1-onu a jejich použití jako léčiv v protinádorové terapii
WO2017103637A1 (en) 2015-12-18 2017-06-22 Blirt S.A. Diphenylpropane compounds and their cytotoxic activity
CN106279082B (zh) * 2016-08-02 2019-02-01 浙江大学 取代的呋喃查耳酮类衍生物及其制备方法
CN111138264B (zh) * 2019-11-29 2023-08-04 温州医科大学 一种丁香醛衍生物及其在制备抗妇科肿瘤药物中的应用
KR102496887B1 (ko) * 2020-10-15 2023-02-06 경상국립대학교산학협력단 부테인 유도체 또는 이의 약학적으로 허용가능한 염을 포함하는 유방암의 예방, 개선 또는 치료용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2084208A1 (en) * 1990-05-17 1991-11-18 Barry Markaverich Growth inhibitors and methods of treating cancer and cell proliferative diseases
IT1271301B (it) * 1994-12-20 1997-05-27 Indena Spa Calconi naturali e sintetici e loro esteri ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno e formulazioni che li contengono

Also Published As

Publication number Publication date
AU742784C (en) 2005-08-18
EP0989973A1 (en) 2000-04-05
DE69831409D1 (de) 2005-10-06
US6147082A (en) 2000-11-14
CN1198802C (zh) 2005-04-27
EP0989973B1 (en) 2005-08-31
CN1261349A (zh) 2000-07-26
PL337361A1 (en) 2000-08-14
NO996287L (no) 2000-02-21
CA2294278C (en) 2007-09-25
DE69831409T2 (de) 2006-06-08
SI0989973T1 (sl) 2006-02-28
ES2244075T3 (es) 2005-12-01
RU2203883C2 (ru) 2003-05-10
AU742784B2 (en) 2002-01-10
CZ294976B6 (cs) 2005-04-13
HUP0003068A3 (en) 2002-02-28
JP4064471B2 (ja) 2008-03-19
KR20010013603A (ko) 2001-02-26
AU8537598A (en) 1999-01-04
CA2294278A1 (en) 1998-12-30
PL190495B1 (pl) 2005-12-30
DK0989973T3 (da) 2005-10-17
HUP0003068A2 (hu) 2001-01-29
CZ459999A3 (cs) 2000-05-17
HK1023770A1 (en) 2000-09-22
SK283077B6 (sk) 2003-02-04
GB9712966D0 (en) 1997-08-27
PT989973E (pt) 2005-11-30
WO1998058913A1 (en) 1998-12-30
ATE303362T1 (de) 2005-09-15
SK179599A3 (en) 2000-06-12
NO314802B1 (no) 2003-05-26
JP2002506439A (ja) 2002-02-26
HU227628B1 (en) 2011-10-28

Similar Documents

Publication Publication Date Title
DK0989973T3 (da) Chalconer med antiproliferativ aktivitet
SE9604793D0 (sv) New polymorphs
DK1200418T3 (da) Nematodicide trifluorbutener
ATE262895T1 (de) Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis
MY132529A (en) Paroxetine hydrochloride anhydrate
ATE225351T1 (de) Thienopyridin und thienopyrimidinderivate und ihre verwendung als entzündungshemmende mittel
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
BR9812837A (pt) Processo para fazer um composto, e, composto
DE69831000D1 (de) Verwendung von cytidin und cytosin-enthaltenden verbindungen zur behandlung von reizmittelgelgebrauch
ATE171873T1 (de) Antiglucocorticoidsteroide zur behandlung von angststörungen
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
DE69805305T2 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
BG105275A (en) Tan-1057 derivatives
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
ES2110258T3 (es) Derivados de 1,3,5(10)-estratrieno activos por via oral.
MXPA02001204A (es) Compuestos calciliticos.
DE60015098D1 (de) 3-cyclopropylmethoxy-4-difluormethoxy-n-(3,5-dichlor-pyrid-4-yl)-benzamid zur behandlung von multipler sklerose
HUP0103712A2 (hu) Paroxetin sók, eljárás az előállításukra és gyógyászati alkalmazásuk
NO975413D0 (no) Koboltmetallagglomerater, samt fremgangsmåte for fremstilling og anvendelse derav
SE9404438D0 (sv) New process
SE9501773D0 (sv) New use
RO116896B1 (ro) Derivaţi pseudocarbaciclinici şi procedeu pentru prepararea acestora
MX9704733A (es) Monomeros de ciclohesan-1-ona 4,4-disubstituidos y compuestos relacionados.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees